Skip to main content

The rising cases of zoonotic diseases to boost Animal Nutrition Market growth

 


Market Overview:

Animal nutrition refers to the nutritional necessities of food-production, companion, or service animals. It is the kind of making or design of feed for animals that make food such as milk or meat or nonfood substances. Nutrients are materials in feed that are utilized by the animal for growth and manufacture.

Competitive Landscape:

Key players involved in the global animal nutrition market are Tata Chemicals, Archer-Daniels-Midland Company, Dow Chemical Company,Evonik Industries AG, Adisseo France SAS, Royal DSM N.V., Kemin Industries, Inc.,  Alltech, BASF SE, Cargill Inc., DuPont, Novozymes A/S, and Nutreco N.V. 

Market Key Drivers:

The rising cases of zoonotic diseases is expected to propel the growth of global animal nutrition market. For instances, as per WHO, around one billion cases of illness and one million cases of fatalities occur due to zoonoses annually.

Increasing demand for safe and nutritious food for animals is anticipated to drive the growth of global animal nutrition market. For instance, as per FAO, necessity for animal derived-protein would double by 2050.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global animal nutrition market owing to the strict lockdown and restrictions imposed by the government. The closure of manufacturing units and the disruption in the supply chain acted as a limitation in the market growth.

Key Takeaways:

The global animal nutrition market is anticipated to exhibit a CAGR of XX % during the forecast period owing to change in requirements of nutrients by the animals. For instance, older animals might have health issues related to aging, which needs varied nutritional requirement such as mineral and vitamin additions. 

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in the global animal nutrition market due to product expansions, approvals and launches. For instance, in July 2022, the Nutrition & Health Division of BASF was expanding its place as an ingredients collaborator for animal nutrition and human nutrition companies.

 

 

 

 

 

 

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Life Sciences BPO Market is Expected to Grow Drastically, Assured By Experts From 2023 To 2028

  The growing cost of drug development is augmenting the growth of the global life sciences BPO market. For instance, according to a study by the Tufts Center for the Study of Drug Development published in the Journal of Health Economics in May 2019, the cost of drug development was US$ 2.6 billion, which included average out-of-pocket costs of US$ 1.4 billion and time costs of US$ 1.2 billion. Also, patent expiration is another key factor propelling the growth of the life sciences BPO market. For instance, the patent for YAZ (drospirenone/ethinylestradiol), which provides an oral contraceptive regimen, is set to expire in 2021. Furthermore, the rising prevalence of chronic disease around the globe is further anticipated to accelerate the growth of the market. North America is projected to lead the global life sciences BPO market due to increasing R&D in cell therapies by key players in the region. For instance, in February 2020, Caribou Biosciences, Inc., a CRISPR genome editin
Post a Comment
Read more

Increasing various research activities is propelling growth of the pediatric vaccines market

  Pediatric Vaccine Market: Global Trends Over the course of the forecast period, rising public awareness of vaccinations and immunisation is anticipated to fuel market expansion for paediatric vaccines worldwide. For instance, the United States recognises January as Cervical Health Awareness Month, promoting the value of routine immunisation and screening in the fight against cancer. Global Pediatric Vaccine Market: Drivers Increasing awareness regarding vaccines and immunization among the populace is expected to boost growth of the global pediatric vaccine market over the forecast period. For instance, in the U.S., the month of January is celebrated as Cervical Health Awareness Month, wherein the importance of regular vaccination and screening in the prevention of cancer is forwarded.
Post a Comment
Read more

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering takes place and which layer of skin is affected. Global epidermolysis bullosa market is estimated to be valued at  US$ 3,
Post a Comment
Read more